Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000242652 | SCV000111504 | benign | not specified | 2015-07-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000227873 | SCV000287005 | benign | Primary ciliary dyskinesia | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000242652 | SCV001365793 | benign | not specified | 2013-02-21 | criteria provided, single submitter | clinical testing | Val1477Ala in exon 25 of DNAH11: This variant is not expected to have clinical significance because it has been identified in 6.1% (8/132) of Mexican chromosomes from a broad population by the 1000 Genomes Project (http://www.ncbi.nlm.nih.gov/projects/SNP; dbSNP rs72657320). |
Fulgent Genetics, |
RCV002498398 | SCV002806635 | benign | Primary ciliary dyskinesia 7 | 2021-09-21 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV002498398 | SCV003799319 | benign | Primary ciliary dyskinesia 7 | 2023-10-12 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004528285 | SCV000307514 | likely benign | DNAH11-related disorder | 2023-11-29 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |